Biochemical Control after HDR Prostate Brachytherapy Boost for T3b Cancer: the Stokes Centre for Urology Experience

Purpose: High dose rate prostate brachytherapy (HDR-PB) allows dose escalation after external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT) and is an effective treatment for patients with high-risk prostate cancer [1,2]. The purpose of this study is to present the experience of the Stokes Centre for Urology with HDR-PB in T3b disease, looking at biochemical control.

Source: Clinical Oncology - December 21, 2023 Category: Radiology Authors: M. Metawe, S. Uribe-Lewis, S. Otter, C. Mikropoulos, C. Perna, S. Langley Source Type: research